Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Comprehensive analysis of circulating viral DNA in maternal plasma at population-scale using low-pass whole-genome sequencing

PROVIDER: PRJNA797267 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18791046.fastq.gz	Fastqsanger.gz
	SRR18791047.fastq.gz	Fastqsanger.gz
	SRR18791048.fastq.gz	Fastqsanger.gz
	SRR18791049.fastq.gz	Fastqsanger.gz
	SRR18791050.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Human plasma peptidomics - Identification and quantification of plasma free salusin-β, an endogenous parasympathomimetic peptide

Project description:We have improved our ultrahigh-yield method, which we named “differential solubilization" (J Proteome Res 9, 2010, 1694-1705), to extract and analyse low-molecular-weight plasma peptides, and initiated a large-scale sequencing of circulating native peptides at concentrations as low as the picomolar level using less than 200 μl of human plasma.

2018-10-26 | PXD003533 | Pride

Project description:Hepatocellular carcinoma circulating tumor cell low pass CNV sequencing

| PRJNA630090 | ENA

Circulating exosomal miRNA profile during term and preterm birth pregnancies – a longitudinal study

Project description:The objective of this study was to characterise the changes in the exosomal miRNA concentrations circulating in the maternal plasma between mothers delivering term and preterm neonates, across gestation using a longitudinal study design. A retrospective stratified study design was used to characterize the miRNA content in exosomes present in maternal plasma of term (n=20 per time point) and preterm birth (PTB) (n=10 per time point) across gestation (i.e. first, second and third trimester).

2019-02-12 | GSE115572 | GEO

Homo sapiens

Project description:Circulating cfDNA based Low-pass WGBS in hepatocellular carcinoma surveillance

| PRJNA564401 | ENA

mouse_APAP

Project description:Comprehensive cataloging of cell-free circulating RNAs using next generation sequencing technology may open a window to assess drug associated adverse effects at the systems level. To explore this potential, we conducted an RNA profiling study using the well-characterized acetaminophen overdose mouse model on liver and plasma with next generation sequencing platforms.

2013-03-08 | E-MTAB-1538 | biostudies-arrayexpress

Circulating microRNA screening of high-risk individuals enrolled in COSMOS lung cancer screening trial.

Project description:Lung cancer is the leading cause of cancer death worldwide. Low-dose computed tomography screening (LDCT) was recently shown to anticipate the time of diagnosis, thus reducing lung cancer mortality. We identifed a serum microRNA signature (the miR-Test) that could identify the optimal target population for LDCT screening. Here, we performed a large-scale validation study of the miR-Test in high-risk individuals enrolled in the Continuous Observation of Smoking Subjects (COSMOS) lung cancer screening program. RT-qPCR of circulating microRNA purified from serum samples. Trizol-LS and miRNEASY Mini kit (Qiagen) were used for miRNA purification. Custom TaqManÂ® Low Density Array microRNA Custom Panel (Life Technologies) was used to screen serum circulating microRNA.

2016-02-29 | E-GEOD-76462 | biostudies-arrayexpress

Analysis of the impact of cellular miRNA signatures on the profiles of circulating miRNA biomarkers (variability data)

Project description:Circulating miRNAs are an emerging class of biomarkers correlating their specific expression patterns to disease states. A considerable proportion of hematopoietically-derived miRNAs are present in plasma with the ability to confound the signature of true circulating miRNA species. We use microarray analysis to catalogue a list of 313 haemotopoetic miRNAs and analyze expression profiles of cell-free miRNAs in individual plasma fractions after calibraiting for cellular miRNA signals. Comprehensive global maps of bona fide circulating miRNA species are presented, and inter-individual varibility and gender-specific expession is explored in populations of healthy individuals. Supernatant 1 (S1) fractions from 8 male and 10 female individuals.

2011-06-17 | E-GEOD-27253 | biostudies-arrayexpress

Identification of a plasma four-microRNA panel as a potential noninvasive biomarker for osteosarcoma

Project description:TaqMan low density array (TLDA) was carried out to screen of the profiles of circulating miRNAs in pooled plasma samples from healthy controls and pre-operative osteosarcoma patients. The expression changes of circulating miRNAs in osteosarcoma patients were identified. To select candidate plasma miRNAs for osteosarcoma detection and monitoring, we employed TLDA technique to screen expression levels of 739 miRNAs in pooled plasma samples from healthy controls and pre-operative osteosarcoma patients (each pooled from 10 individuals).

2015-01-13 | E-GEOD-64915 | biostudies-arrayexpress

The impact of the anticoagulant type in blood collection tubes on circulating plasma miRNA profiles revealed by small RNA sequencing

Project description:Pre-analytic factors have a significant influence on circulating miRNA profiling. The aim of this study was the comprehensive NGS-based assessment of the impact of anticoagulant type in blood collection tubes on circulating plasma miRNA profiles.

2022-09-07 | GSE200970 | GEO

Umbilical Cord Blood miRNA Profiling: Links to Maternal Metabolism and Neonatal Traits

Project description:We performed miRNA profiling of umbilical cord plasma (UCP) to investigate the association of circulating neonatal miRNAs with maternal metabolic parameters and neonatal anthropometric, metabolic, and inflammatory characteristics in healthy pregnancies. We collected data and UCP samples from 16 pregnancies, in equal parts with normal weight and overweight mothers, and male and female neonates. We performed next-generation miRNA sequencing and analysed metabolic and inflammatory parameters in UCP. Our results revealed that the majority of UCP miRNAs are sensitive to maternal and neonatal characteristics, particularly to maternal BMI, Our study highlights the susceptibility of UCP miRNAs to maternal metabolism, demonstrates their association with neonatal metabolic and inflammatory traits, and underscores the potential role of circulating umbilical cord blood miRNAs in fetal metabolism and development.

2025-03-01 | GSE276266 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data